US, EU regulators to review higher-dose Spinraza for use in SMA
Regulators in the U.S. and the European Union have agreed to review Biogen’s applications seeking approval of a higher dose…
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Regulators in the U.S. and the European Union have agreed to review Biogen’s applications seeking approval of a higher dose…
Gratitude and support from family and healthcare staff can help people with spinal muscular atrophy (SMA) feel more positive,…
Slightly more than half of spinal muscular atrophy (SMA) patients in Australia who gave feedback for a study on…
Scholar Rock’s apitegromab led to motor function improvements over a year of treatment in young adults and children…
SMA Europe has released a new documentary titled “One Community. Shared Dreams.” as part of an awareness initiative…
A baby’s respiratory failure and need for mechanical ventilation were traced to spinal muscular atrophy with respiratory distress type…
Spinal muscular atrophy (SMA) may involve changes that occur before birth, during an embryo’s development in the womb, and…
Three years of treatment with apitegromab, a muscle-targeting therapy being developed by Scholar Rock, continues to provide clinical…
A woman with a long history of muscle weakness was found to have spinal muscular atrophy (SMA) in her…
A method that uses laser light to get information from inside the body in a noninvasive way may help monitor…
Get regular updates to your inbox.